Your browser doesn't support javascript.
loading
Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression cut-off.
Chun, Helen M; Milligan, Kyle; Boyd, Mary Adetinuke; Abutu, Andrew; Bachanas, Pamela; Dirlikov, Emilio.
Afiliação
  • Chun HM; Division of Global HIV/TB, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA.
  • Milligan K; Division of Global HIV/TB, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA.
  • Boyd MA; Peraton, Herndon, VA, USA.
  • Abutu A; Division of Global HIV/TB, Global Health Center, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Bachanas P; Division of Global HIV/TB, Global Health Center, Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Dirlikov E; Division of Global HIV/TB, Global Health Center, Centers for Disease Control and Prevention, Atlanta, GA.
AIDS ; 37(13): 2081-2085, 2023 11 01.
Article em En | MEDLINE | ID: mdl-37503650
BACKGROUND: Virologic suppression has been defined using a HIV viral load of less than 1000 copies/ml. Low-level viremia (51-999 copies/ml) is associated with an increased risk of virologic failure and HIV drug resistance. METHODS: Retrospective data from persons with HIV (PWH) who initiated ART between January 2016 and September 2022 in Nigeria were analyzed for virologic suppression at cut-off values less than 1000 copies/ml. RESULTS: In 2022, virologic suppression at less than 1000 copies/ml was 95.7%. Using cut-off values of less than 400, less than 200 and less than 50 copies/ml, virologic suppression was 94.2%, 92.5%, and 87%, respectively. DISCUSSION: Monitoring virologic suppression using lower cut-off values, alongside differentiated management of low-level viremia, may help Nigeria achieve HIV epidemic control targets.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV Idioma: En Ano de publicação: 2023 Tipo de documento: Article